[6]
1. Imai H, Ohta K, Yoshida A, Suzuki S, Hashizume K, Usami S, Kikuchi T mu-crystallin, New candidate protein in endotoxin-induced uveitis. Invest Opthalmol Vis Sci 51: 3554-3559, 2010.
2. Suzuki S, Takei M, Ehara T, Nishio S, Inaba H, Hashizume K : Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells. BMJ Case Report published on 26, July, 2009.
3. Takei M, Suzuki S, Sato A, Yamazaki M, Shi S, Sato Y, Hashizume K : Five cases of severe hyponatremia in the elderly successfully treated with low doses of hydrocortisone. Geriatr Gerontol Int 9: 391-394, 2009
4. Suzuki S, Takei M, Hashizume K: Postprandial thermoregulation in elderly diabetic patients. In: Lignalli AT (ed), Handbook of Type 2 Diabetes in the Middle Aged and Elderly pp603-608, Nova Science Publishers, Hauppauge, NY, 2009
5. Suzuki S, Takei M, Nishio S, Inaba H, Sato A, Yamazaki M, Shinomiya K, Hashizume K : Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with Graves' hyperthyroidism. Horm Metab Res 41: 548-553, 2009
6. Suzuki S, Hashizume K : Do PPARgamma ligands suppress the growth of cholangiocarcinoma or the cholangiohepatitis induced by the tumor? PPAR Res : 587401, 2008
7. Suzuki S, Mori J Yamazaki M, Sato A, Hosoda W, Hashizume K : Beneficial effects of pioglitazone on cholangiohepatitis induced by bile duct carcinoma. Inter Med 46: 1723-1727, 2007
8. Suzuki S, Mori J, Hashizume K : m-crystallin, a NADPH-dependent T3 binding protein in cytosol. Trends Endocrinol Metab 18: 286-28, 2007
9. Suzuki S, Suzuki N, Mori J, Oshima A, Usami S, Hashizume K : m-Crystallin as an intracellular 3,5,3'-triiodothyronine holder in vivo. , Mol Endocrinol 21: 885-894, 2007
10. Oshima A, Suzuki S, Takumi Y, Hashizume K, Abe S, Usami S : CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea. J Med Genet 43:e25, 2006
11. Komatsu A, Suzuki S, Inagaki T, Yamashita K, Hashizume K : A kindred with Cockayne syndrome caused by multiple splicing variants of the CSA gene. Am J Med Genet 128A:67-71, 2004
12. Inagaki T, Suzuki S, Miyamoto T, Takeda T, Yamashita K, Komatsu A, Yamauchi K, Hashizume K : The retinoic acid-responsive proline-rich protein is identified in promyeloleukemic HL-60 cells. J Biol Chem 278: 51685-51692, 2003
13. Suzuki S, Mori J-I, Kobayashi M, Inagaki T, Komatsu A, Yamashita K, Takeda T, Miyamoto T, Ichikawa K, Hashizume K : Presence of functional domains in molecule of NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine (T3)-binding protein (p38CTBP): Analyses with deletion mutants. Horm Metab Res 35: 577-582, 2003
14. Suzuki S, Mori J, Kobayashi K, Inagaki T, Inaba H, Komatsu A, Yamashita K, Takeda T, Miyamoto T, Ichikawa K, Hashizume K : Cell Specific expression of NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine (T3) binding protein (CTBP). Eur J Endocrinol 148:259-268, 2003
15. Mori J-I, Suzuki S, Kobayashi M, Inagaki T, Komatsu A, Takeda T, Miyamoto T, Ichikawa K, Hashizume K Nicotinamide adenine dinucleotide phosphate-dependent cytosolic T3 binding protein as a regulator for T3-mediated transactivation. Endocrinology 143: 1538-1544, 2002.
16. Hara M, Suzuki S, Mori J, Yamashita K, Kumagai M, Sakuma T, Kakizawa T, Takeda T, Miyamoto T, Ichikawa K, Hashizume K: Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells.: Studies with retinoic acid receptors- and retinoid x receptors-specific ligands. Thyroid 12: 1023-1034, 2000
17. Mori J, Suzuki S, Hara M, Kaneko A, Yamashita K, Kumagai M, Sakuma T, Kakizawa T, Yamazaki M, Takeda T, Miyamoto T, Ichikawa K, Hashizume K: Characterization of two novel retinoic acid-resistant cell lines derived from HL-60 cells following long-term culture with all-trans retinoic acid. Jpn J Cancer Res 90(6): 660-668, 1999
18. Kaneko A, Suzuki S, Hara M, Mori J, Kumagai M, Yajima H, Yamashita K, Kakizawa T, Yamazaki M, Takeda T, Miyamoto T, Ichikawa K, Hashizume K 1,25-dihydroxyvitamin D3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells. Biochem Biophys Res Comm 255(2): 371-376, 1999
19. Suzuki S, Kobayashi H, Sekine R, Kumagai M, Mikoshiba M, Mori J, Hara M, Ichikawa K, Hashizume K. 3,5,3'-Triiodo-L-thyronine potentiates all-trans retinoic acid-induced apoptosis during differentiation of the promyeloleukemic cell HL60. Endocrinology 1997 138: 805-809.
20. Suzuki S, Hashizume K, Ichikawa K, Takeda T: Ontogenesis of the High Affinity NADPH-Dependent Cytosolic 3,5,3'-Triiodo-L-Thyronine-Binding Protein in Rat. Endocrinology 129: 2571-2574, 1991
21. Kobayashi M, Hashizume K, Suzuki S, Ichikawa K, Takeda T: A novel NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine-binding protein (CTBP;5.1S) in rat liver: a comparison with 4.7S NADPH-dependent CTBP. Endocrinology 129:1701-1708, 1991
